ONCOLOGY NURSING March 2012 Ermatingen (Lake Constance), Switzerland

Transcription

1 MASTERCLASS ERMATINGEN 17/03/12 5 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING March 2012 Ermatingen (Lake Constance), Switzerland Chairs: A. Margulies, CH - S. Faithfull, UK Scientific Coordinator: L. Sharp, SE Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans

2 The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care. Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosocial consequences of cancer therapy. Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant s role in clinical leadership. In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Special joint sessions in symptom management, supportive care and palliative care will be supported by workshops and coaching to explore nursing practice in these speciality areas. Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up. Aims and objectives The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care. Learning outcomes: n Understand new developments in oncology disease management. n Recognise and describe acute and late adverse effects of cancer and its treatment. n Identify complex patient needs across the diagnostic and oncology treatment trajectory. n Demonstrate advanced communication skills in managing oncology nursing care. n Critically appraise the evidence for cancer symptom management and intervention. n n Reflect on theoretical underpinnings of decision making. Describe the role of the advanced oncology nurse in leading clinical nursing care. The Masterclass is: n A 5-day residential educational event n Full immersion n Clinically-oriented n Multidisciplinary n An international faculty of top experts delivering advanced concept Accreditation The Masterclass programme will be accredited by the European Oncology Nursing Society.

3 Teaching format The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in. All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the Masterclass in Nursing Oncology will attend selected medical sessions whilst the advanced communication skills will be attended only by nurses. Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion. FACULTY (as of January 2012) A. Albini, IRCCS MultiMedica, Milan, IT A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH T. Brodowicz, AKH Wien, Vienna, AT G. Cavaletti, Bicocca University, Department of Neuroscience and Biomedical Technologies, Milan, IT G. Curigliano, European Institute of Oncology, Div. of Medical Oncology, Milan, IT A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT M. Ghielmini, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK K.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie und Hämatologie, Oldenburg, DE A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Dept. of Medical Oncology, Bellinzona, CH G.J. Poston, Aintree University Hospital, Dept. of Surgery, Liverpool, UK N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR K. Redmond, Cancer World Magazine, Lugano, CH D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of Haemato-Oncology, Antwerp, BE S. Segaert, University Hospital Sint-Rafaël, Dermatology Department, Leuven, BE C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH E. Van Cutsem, University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, BE J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE G. Viale, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH E. Von Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, NL M. Wells, University of Dundee, Dundee, UK

4 PROGRAMME SATURDAY, 17 MARCH Participants' arrival, airport transfer, registration 14:30 Greetings and introduction to Masterclass in Oncology Nursing: Aims and objectives A. Margulies, CH S. Faithfull, UK 15:00 Group introductions A. Margulies, CH S. Faithfull, UK Participants 15:30 Role development: Advanced oncology nursing practice S. Faithfull, UK 16:15 Developing the evidence base for oncology nursing practice 17:00 Overview of Rx modalities and new developments in the treatment of prostate cancer L. Sharp, SE E. Van Muilekom, NL 17:50 Coffee break 18:20 Coaching: two groups A. Margulies, CH S. Faithfull, UK 20:30 Welcome dinner SUNDAY, 18 MARCH 8:30 Clinical session Breast cancer I Chair: G. Viale, IT n Pathology of breast cancer G. Viale, IT n Early systemic treatment I: Neoadjuvant O. Pagani, CH n Early systemic treatment I: Neoadjuvant, surgical viewpoint W. Gatzemeier, IT n Early systemic treatment II: Adjuvant G. Curigliano, IT 10:45 Coffee break 11:15 Radiotherapy today S. Faithfull, UK 12:00 "Targeted" therapy A. Margulies, CH 12:15 Case studies presentation and discussion + plenary presentation Participants 13:15 Lunch

5 14:30 Spotlight session 1 Haematological diseases M. Ghielmini, CH 15:30 Introduction to communication skills + Assessing psychosocial health A. Hoy, UK - A. Arber, UK 16:30 Coffee break 17:00 Introduction to communication skills (cont.) A. Hoy, UK - A. Arber, UK 19:30 Dinner MONDAY, 19 MARCH Communication skills workshop Group 1 A. Hoy, UK - A. Arber, UK 8:30 Clinical session Gynaecological cancers Chair: J.B. Vermorken, BE n Ovarian cancer J.B. Vermorken, BE n Cervical and endometrial cancers C. Sessa, CH 10:30 Coffee break Communication skills workshop Group 2 A. Hoy, UK - A. Arber, UK 11:00 Clinical session Head and neck cancer Chair: J. Bernier, CH n Prognostic factors and surgical approach A. Dietz, DE n Radiotherapy J. Bernier, CH n Systemic therapy J.B. Vermorken, BE 13:00 Lunch 14:30 Assessment skills S. Faithfull, UK 15:30 Research in clinical nursing M. Wells, UK 16:30 Spotlight session 3 Cancer and pregnancy N. Pavlidis, GR 17:00 Coffee break 17:30 10 min review gynaecology - Hand and neck sessions Case study presentation and discussions + plenary presentation Participants 19:30 Dinner

6 TUESDAY, 20 MARCH 8:30 Clinical session Gastro-intestinal tumours I Chair: E. Van Cutsem, BE Colon cancer: n Adjuvant and neoadjuvant treatment of colorectal cancer K.H. Köhne, DE n Systemic treatment in advanced disease E. Van Cutsem, BE 10:00 Sponsored lecture Metastasectomies in colorectal cancer (SPCC lecture by Merk) G.J. Poston, UK 10:30 Coffee break 11:00 Market place Honing symptom management expertise 13:30 Lunch n Radiodematitis M. Wells, UK n Skeletal events E. Von Muilekom, NL n Periferal Neuro / target-skin A. Margulies, CH n Pelvic S. Faithfull, UK 14:30 Sponsored lecture Maintenance treatment in advanced non small cell lung cancer: a new treatment paradigm? (SPCC lecture by Lilly) T. Brodowicz, AT 15:00 e-eso online session on The importance of prevention A. Decensi, Galliera Hospital, Genoa, IT 16:00 Free time 19:30 Dinner WEDNESDAY, 21 MARCH 8:30 Clinical session Lung cancer and mesothelioma I Chair: R.A. Stahel, CH n Surgery W. Weder, CH n Radiotherapy C. Faivre-Finn, UK n Non-small cell lung cancer systemic therapy R.A. Stahel, CH 10:30 Coffee break 11:00 Clinical session Lung cancer and mesothelioma II Chair: R.A. Stahel, CH n Small cell lung cancer C. Faivre-Finn, UK n Mesothelioma R.A. Stahel, CH

7 12:00 Case study presentation and discussions + plenary presentation Participants 13:00 Lunch 14:15 Joint medics and nursing session Side effects of systemic treatment and their management n Cardiovascular toxicity A. Albini, IT n Skin toxicity S. Segaert, BE n Neurotoxicity G. Cavaletti, IT 15:30 Joint medics and nursing session Oral therapy: Adherence, compliance and drug interaction K. Redmond, CH 16:00 Coffee break 16:30 Joint medics and nursing session Palliative care n Pain control D. Schrijvers, BE n Advanced disease management A. Hoy, UK 18:00 Examination 19:30 Dinner THURSDAY, 22 MARCH 8:30 Survivorship S. Faithfull, UK 9:30 Developing your clinical practice Pictures speak louder than words A. Margulies, CH S. Faithfull, UK Participants 10:30 Coffee break 11:00 Presentation of results / Coaching Session Participants 12:00 Closure

8 GENERAL INFORMATION PROFILE OF THE IDEAL CANDIDATE n Nurse with a masters degree (obtained in the past 5 years) in nursing / oncology nursing or equivalent in the country of residence n Is working at an advanced nursing practice level, and has had at least 2-3 years of clinical oncology nursing practice n Is involved in direct patient care, cancer nursing research, cancer nursing education (post-graduate and master level), or the management, organisation and co-ordination of cancer patient care n Is fluent in English (reading and speaking) n Is a member of an EONS member society or is an individual member ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY AND SUCCESSFUL APPLICANTS ARE GRANTED FREE REGISTRATION AND ACCOMMODATION APPLICATION DEADLINE: 1 DECEMBER 2011 HOW TO APPLY n Complete Application Form (available at or on request to eons.secretariat@cancernurse.eu) n A short curriculum vitae including topic of master s thesis (or similar) and details of further post registration training n Provide a short letter (max. 200 words) about motivation for attending n Supporting letter from head of department or mentor n Provide an abstract of 300 words on advanced nursing practice : my experience and practice Only applications with all required attachments will be considered. FOR FURTHER INFORMATION: eons.secretariat@cancernurse.eu European Oncology Nursing Society, EONS Secretariat Att. Rudi Brike E. Mounierlaan Brussels, Belgium Phone , Fax Further information is also available at: